One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer said.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

ASML and Alphabet are two of the few undervalued AI stocks around today. Rising demand for semiconductors should help ASML grow revenue. Alphabet is a leader in AI on both consumer and enterprise applications.

Alphabet Inc. (NASDAQ:GOOGL) is one of the 10 AI Stocks Making Waves on Wall Street. On June 25, Google’s DeepMind announced the launch of AlphaGenome: an AI model that helps scientists better understand DNA,